About Celestra Health Systems

Celestra Health Systems provides a software application that employs real-time health monitoring and disease indication algorithms to track patient health metrics. This technology enables healthcare providers to detect potential health issues early, enhancing patient outcomes and alleviating pressure on healthcare resources.

```xml <problem> Current methods for assessing gait and mobility in patients with neurological conditions, such as Multiple Sclerosis and Parkinson's Disease, often rely on infrequent, in-clinic evaluations or expensive gait laboratories, failing to capture real-world mobility patterns and subtle changes in gait over time. These limitations hinder timely intervention and personalized treatment adjustments. </problem> <solution> Celestra Health Systems offers a digital biomarker platform that utilizes smart insoles and AI-powered gait analysis to continuously monitor and quantify a patient's walking quality in their natural environment. The FDA-cleared Class II medical device unobtrusively collects gait data via wearable insoles equipped with gyroscopes, accelerometers, and pressure sensors. This data is transmitted to a secure cloud platform where proprietary AI algorithms generate objective gait metrics and walking quality scores. Clinicians and patients can access these insights through a web portal and smartphone app, enabling early detection of disease progression, personalized treatment plans, and improved patient outcomes. </solution> <features> - Smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to capture comprehensive gait data - Wireless data transmission to a secure, HIPAA-compliant cloud platform - Proprietary AI algorithms for objective gait analysis and walking quality scoring - Detection of specific walking events, such as foot drops, and identification of walking phenotypes (e.g., ataxic, spastic) - Clinician web portal for accessing patient data, trend analysis, and notifications of significant changes - Patient smartphone app for personalized insights and progress tracking - Benchmarked against state-of-the-art gait laboratories, demonstrating equivalent accuracy at a fraction of the cost - Continuous monitoring to detect subtle changes in gait that may not be apparent in traditional clinical assessments </features> <target_audience> The primary target audience includes neurologists, hospitals, and pharmaceutical companies focused on managing and treating Multiple Sclerosis, Parkinson's Disease, and other neurological conditions affecting mobility. </target_audience> ```

What does Celestra Health Systems do?

Where is Celestra Health Systems located?

Celestra Health Systems is based in Ottawa, Canada.

When was Celestra Health Systems founded?

Celestra Health Systems was founded in 2021.

Location

Ottawa, Canada

Founded

2021

Employees

9 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Celestra Health Systems

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

celestrahealth.com 200+

Founded 2021 – Ottawa, Canada

Funding

No funding information available.

Team (5+)

No team information available.

Company Description

Problem

Current methods for assessing gait and mobility in patients with neurological conditions, such as Multiple Sclerosis and Parkinson's Disease, often rely on infrequent, in-clinic evaluations or expensive gait laboratories, failing to capture real-world mobility patterns and subtle changes in gait over time. These limitations hinder timely intervention and personalized treatment adjustments.

Solution

Celestra Health Systems offers a digital biomarker platform that utilizes smart insoles and AI-powered gait analysis to continuously monitor and quantify a patient's walking quality in their natural environment. The FDA-cleared Class II medical device unobtrusively collects gait data via wearable insoles equipped with gyroscopes, accelerometers, and pressure sensors. This data is transmitted to a secure cloud platform where proprietary AI algorithms generate objective gait metrics and walking quality scores. Clinicians and patients can access these insights through a web portal and smartphone app, enabling early detection of disease progression, personalized treatment plans, and improved patient outcomes.

Features

Smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to capture comprehensive gait data

Wireless data transmission to a secure, HIPAA-compliant cloud platform

Proprietary AI algorithms for objective gait analysis and walking quality scoring

Detection of specific walking events, such as foot drops, and identification of walking phenotypes (e.g., ataxic, spastic)

Clinician web portal for accessing patient data, trend analysis, and notifications of significant changes

Patient smartphone app for personalized insights and progress tracking

Benchmarked against state-of-the-art gait laboratories, demonstrating equivalent accuracy at a fraction of the cost

Continuous monitoring to detect subtle changes in gait that may not be apparent in traditional clinical assessments

Target Audience

The primary target audience includes neurologists, hospitals, and pharmaceutical companies focused on managing and treating Multiple Sclerosis, Parkinson's Disease, and other neurological conditions affecting mobility.